Developer docs
API playgroundTry for free, no card

Search company profiles

InnoScot Health

Full company profile

uuid0009rbn

Namestring
InnoScot Health
Legal namestring
InnoScot Health
Websiteurl
innoscot.com
Company typeenum
Private
Founded yearint
2002
Descriptiontext

InnoScot Health is a Glasgow-based healthcare innovation support agency that has operated in formal partnership with NHS Scotland since 2002 (rebranded from Scottish Health Innovations Ltd in June 2022). The organisation's function is to identify, protect, develop and commercialise innovations originating from NHS Scotland staff, providing an end-to-end pathway covering idea assessment, intellectual property protection (patents, trademarks, copyright, design rights), regulatory affairs (ISO 13485:2016 accredited), funding facilitation (Scottish Enterprise, Innovate UK), project management and commercialisation. Over 23 years it has assessed more than 2,000 innovative ideas, protected 250+ NHS inventions, formed 7 spin-out companies (including CardioPrecision, Aurum Biosciences, MR CoilTech and Touch Bionics) and negotiated 25+ UK and international commercial licence deals.

The product portfolio spans medical devices (SCRAM airway management range, Patient Transfer Scale, Cozy Cuddle Scrubs, Rhinopinch, SARUS Hood) and digital health tools (iGrading diabetic retinopathy platform with NHS Grampian/University of Aberdeen, Peekaboo Vision with NHS Greater Glasgow and Clyde, and national Decision Support Tools). InnoScot Health is structured as a company limited by guarantee, owned equally by Scottish Ministers, NHS Tayside and NHS Golden Jubilee, with its activities overseen by the Scottish Government's Chief Scientist Office. It is not a conventional commercial enterprise: services are provided at no direct cost to NHS staff, and revenue derives from a Scottish Government grant, supplemented by licensing royalties, equity in spinouts, and a small but growing line of external regulatory/QMS services (e.g., the MR CoilTech ISO 13485 contract). The go-to-market is a 'triple helix' model that engages the NHS, industry and academia through innovation calls, webinars, the NHS Clinical Entrepreneur Programme, regional competitions, and direct consultation.

Short descriptiontext

InnoScot Health is a Glasgow-based innovation support agency that identifies, protects, develops and commercialises healthcare innovations from NHS Scotland staff on behalf of the Scottish Government, having assessed 2,000+ ideas, protected 250+ IP assets and formed 7 spinouts since 2002.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersGlasgow, United Kingdom
HQ citystring
Glasgow
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare innovation consulting, medical device commercialisation, NHS innovation services, intellectual property licensing, regulatory compliance services
Industry2 codes
1Health Access & Social Care Innovations (Community Health, Telehealth for Underserved)
CodeBPAGALAGPrimaryYes
2Communicable Disease Prevention & Control (HIV/AIDS, TB, Malaria, NTDs)
CodeBPADAIAAPrimaryNo
Product category
Healthcare Innovation Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1NHS Innovation Support Services
TypeLicensing Royalties
Description

As a company limited by guarantee owned by Scottish Ministers, NHS Tayside, and NHS Golden Jubilee, InnoScot Health is funded by the Scottish Government Chief Scientist Office. Revenue is generated through successful commercialisation of NHS innovations including licensing deals, equity in spinouts, and commercial licence agreements.

innoscot.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

InnoScot Health is a publicly funded healthcare innovation support agency that works in partnership with NHS Scotland to identify, protect, develop and commercialise innovations originating from healthcare professionals. It delivers an end-to-end innovation pathway covering idea evaluation, intellectual property protection (patents, trademarks, copyright and design rights), regulatory compliance, funding facilitation, and commercialisation support leading to licensing deals or spin-out company formation. Its services are provided at no direct cost to NHS Scotland staff, with revenue generated through successful commercialisation, licensing royalties and equity in spinouts.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Over 2,000 innovative ideas received and evaluated since 2002
+3 more records
Product overview1 text field

InnoScot Health is a healthcare innovation support agency operating as a platform-plus-services model. Rather than a single unified product, it offers a comprehensive innovation pathway spanning idea evaluation, IP protection, regulatory compliance, funding, development, and commercialisation. Its portfolio includes supported medical devices (SCRAM Portfolio, Patient Transfer Scale, Cozy Cuddle Scrubs), digital health tools (Decision Support Tools, iGrading, Peekaboo Vision), and spinout companies (Aurum Biosciences, CardioPrecision, MR CoilTech). The organisation has received and evaluated over 2000 innovative ideas, protected over 250 NHS inventions, and formed 7 spin-out companies.

Product and service9 records
1SCRAM Portfolio (Structured CRitical Airway Management)
CategoryMedical Device
Description

Airway management solution for critically unwell patients, including the Paediatric SCRAM Bag adopted at a Glasgow children's hospital and the Surgical SCRAM for theatre settings. Licensed/commercialised via InnoScot Health's NHS innovation pathway for use by hospitals and clinical teams.

2Patient Transfer Scale
CategoryMedical Device
Description

Medical device enabling accurate weight measurement of patients during transfer without requiring additional handling steps. Commercialised via InnoScot Health's NHS innovation pathway for use in hospital and clinical settings.

3Cozy Cuddle Scrubs (by Stacey)
CategoryMedical Device
Description

Modified theatre scrubs enabling birthing partners to provide immediate skin-to-skin contact with newborns after caesarean section, made from cost-effective upcycled NHS fleeces. Developed for NHS neonatal and maternity care settings.

4Rhinopinch
CategoryMedical Device
Description

Simple but effective medical device for nasal treatment, developed and commercialised through the NHS Scotland innovation pathway by InnoScot Health.

5SARUS Hood
CategoryMedical Device
Description

Respiratory/airway device for patient care, supported and commercialised through the InnoScot Health NHS Scotland innovation pathway.

6iGrading Platform
CategoryDigital Health Tool
Description

Diabetic retinopathy screening tool using automated image grading, developed with NHS Grampian and the University of Aberdeen and commercialised through InnoScot Health for NHS and clinical use.

7Peekaboo Vision
CategoryDigital Health Application
Description

Eye health application for vision screening and assessment, created by NHS Greater Glasgow and Clyde and commercialised through the InnoScot Health innovation pathway.

8Decision Support Tools (Scotland)
CategoryDigital Health Platform
Description

National digital decision support platform providing a once-for-Scotland source of digital tools to support clinical decision-making across NHS Scotland, commercialised via InnoScot Health.

9NHS Innovation Support and Commercialisation Services
CategoryInnovation Support Services
Description

End-to-end innovation pathway services for NHS Scotland healthcare professionals and partner organisations, covering idea evaluation, intellectual property protection, regulatory compliance, funding access, development management and commercialisation. Provided at no direct cost to NHS Scotland staff under the Scottish Government Chief Scientist Office remit.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership14 partners
Strategic tierRegionalTypeStrategic or Co-development PartnerAnnounced on2023-04-01
Description

Regional partnership for innovation competition stimulating innovative thinking in the north east of Scotland with unique healthcare requirements.

Strategic tierSignificantTypeStrategic or Co-development PartnerAnnounced on2022-04-01
Description

Signed contract in 2022 to provide ISO 13485:2016 Quality Management System implementation and ongoing regulatory advice and project management for MRI RF coil manufacturer.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

InnoScot Health works in formal partnership with NHS Scotland to identify, protect, develop and commercialise new innovations from healthcare professionals. This is the organisation's primary partnership and reason for existence.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Activity overseen by the Scottish Government's Chief Scientist Office with annual operating plans aligned to strategic objectives and funding provisions.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

One of three equal co-owners of InnoScot Health (alongside Scottish Ministers and NHS Golden Jubilee) representing the NHS in Tayside region.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

One of three equal co-owners of InnoScot Health representing the Golden Jubilee National Hospital and regional surgical centre.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborative group supporting Scottish participation in NHS CEP including Digital Health & Care Innovation Centre (DHI), NHS Education for Scotland (NES), Techscaler, Scottish Enterprise, and Chief Scientist Office.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

EPSRC-funded initiative led by University of Dundee and Heriot-Watt University; InnoScot Health is on the steering committee providing regulatory expertise to support MedTech innovators in Tayside region.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Key funding and business development partner providing access to grants, investment, and commercialisation support for healthcare innovators.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Collaboration between Glasgow School of Art and University of Strathclyde providing expertise in digital health and social care innovation; co-presenter of ecosystem workshops with InnoScot Health.

11MHRA (Medicines and Healthcare products Regulatory Agency)
Strategic tierMajorTypeTechnology or Integration
Description

UK regulatory body responsible for regulating medicines and medical devices; InnoScot Health provides regulatory expertise aligned with MHRA requirements for UK market access.

innoscot.com
Strategic tierSpinoutTypeStrategic or Co-development Partner
Description

InnoScot Health spinout company advancing less invasive cardiovascular surgical solutions; lifesaving technology for structural heart disease making international impact.

Strategic tierSpinoutTypeStrategic or Co-development Partner
Description

NHS spinout developing breakthrough stroke technology with potential new treatments; showcasing innovation at international life sciences events.

Strategic tierSpinoutTypeStrategic or Co-development Partner
Description

InnoScot Health's first spinout success; received six-figure investment from Scottish Enterprise for next generation prosthetics development.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

UK government agency that funds, enables, and delivers health and care research across the NHS. Overlaps with InnoScot's translational and commercialisation remit as a much larger national infrastructure body.

TypeBroad incumbent
Description

Major charitable foundation funding health research and translation, including translational funding programmes that overlap with InnoScot's commercialisation pathway. Operates at much larger scale across UK and globally.

TypeDirect peer
Description

Greater Manchester's NHS-academic-industry innovation partnership identifying, developing, and commercialising innovations. Operates a structurally similar NHS innovation intermediary model in a different UK region.

TypeDirect peer
Description

UK medical research charity that translates early-stage science into treatments, diagnostics, and medical devices. Comparable mission of moving NHS-adjacent research into commercial outcomes via spinouts and licensing.

TypeDirect peer
Description

NHS-wide programme supporting clinical entrepreneurs with mentoring, education, and commercialisation support. Shares InnoScot's NHS-innovator support mission and is an active partner in Scotland.

TypeBroad incumbent
Description

Translational arm of Cancer Research UK that develops and commercialises discoveries from CRUK-funded research via spinouts, licences, and industry collaborations. Highly analogous innovation-to-commercialisation model in a different therapy vertical.

TypeRegional player
Description

London-focused life sciences and MedTech cluster organisation promoting investment, commercialisation, and industry partnerships. Comparable NHS-academia-industry bridge role but operating in a different UK geography.

TypeBroad incumbent
Description

Scotland's national economic development agency with a dedicated Life Sciences team providing commercialisation funding and support to health businesses. Directly listed as an InnoScot partner and operates an overlapping Scottish remit.

9Digital Health & Care Innovation Centre (DHI)
TypeEmerging player
Description

Scottish innovation centre focused on digital health and social care co-design between academia, NHS, and industry. Active InnoScot partner with partially overlapping scope in digital health innovation.

TypeDirect peer
Description

The 15 Health Innovation Networks (formerly Academic Health Science Networks) across England provide NHS-aligned innovation support, adoption, and commercialisation services. Closest direct functional peers to InnoScot Health operating within the NHS ecosystem.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

InnoScot Health

Healthcare Innovation Servicesinnoscot.com

InnoScot Health is a Glasgow-based innovation support agency that identifies, protects, develops and commercialises healthcare innovations from NHS Scotland staff on behalf of the Scottish Government, having assessed 2,000+ ideas, protected 250+ IP assets and formed 7 spinouts since 2002.

What InnoScot Health does

InnoScot Health is a Glasgow-based healthcare innovation support agency that has operated in formal partnership with NHS Scotland since 2002 (rebranded from Scottish Health Innovations Ltd in June 2022). The organisation's function is to identify, protect, develop and commercialise innovations originating from NHS Scotland staff, providing an end-to-end pathway covering idea assessment, intellectual property protection (patents, trademarks, copyright, design rights), regulatory affairs (ISO 13485:2016 accredited), funding facilitation (Scottish Enterprise, Innovate UK), project management and commercialisation. Over 23 years it has assessed more than 2,000 innovative ideas, protected 250+ NHS inventions, formed 7 spin-out companies (including CardioPrecision, Aurum Biosciences, MR CoilTech and Touch Bionics) and negotiated 25+ UK and international commercial licence deals.

The product portfolio spans medical devices (SCRAM airway management range, Patient Transfer Scale, Cozy Cuddle Scrubs, Rhinopinch, SARUS Hood) and digital health tools (iGrading diabetic retinopathy platform with NHS Grampian/University of Aberdeen, Peekaboo Vision with NHS Greater Glasgow and Clyde, and national Decision Support Tools). InnoScot Health is structured as a company limited by guarantee, owned equally by Scottish Ministers, NHS Tayside and NHS Golden Jubilee, with its activities overseen by the Scottish Government's Chief Scientist Office. It is not a conventional commercial enterprise: services are provided at no direct cost to NHS staff, and revenue derives from a Scottish Government grant, supplemented by licensing royalties, equity in spinouts, and a small but growing line of external regulatory/QMS services (e.g., the MR CoilTech ISO 13485 contract). The go-to-market is a 'triple helix' model that engages the NHS, industry and academia through innovation calls, webinars, the NHS Clinical Entrepreneur Programme, regional competitions, and direct consultation.

InnoScot Health firmographics

Firmographics
Name
InnoScot Health
Legal name
InnoScot Health
Website
https://innoscot.com
Company type
Private
Founded year
2002
Operating status
Operating
Headcount range
11–50 employees
Short description
InnoScot Health is a Glasgow-based innovation support agency that identifies, protects, develops and commercialises healthcare innovations from NHS Scotland staff on behalf of the Scottish Government, having assessed 2,000+ ideas, protected 250+ IP assets and formed 7 spinouts since 2002.
Ownership category
akta.pro rank

InnoScot Health industry classification

Industry
Product category
Healthcare Innovation Services
akta.pro primary industry
Health Access & Social Care Innovations (Community Health, Telehealth for Underserved) (BPAGALAG)
akta.pro secondary industry
Communicable Disease Prevention & Control (HIV/AIDS, TB, Malaria, NTDs) (BPADAIAA)

Keywords

  • Healthcare innovation consulting
  • Medical device commercialisation
  • NHS innovation services
  • Intellectual property licensing
  • Regulatory compliance services

Where InnoScot Health is headquartered

Location

Headquarters

HQ city
Glasgow
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

InnoScot Health business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Others

Revenue model

  1. NHS Innovation Support Services: As a company limited by guarantee owned by Scottish Ministers, NHS Tayside, and NHS Golden Jubilee, InnoScot Health is funded by the Scottish Government Chief Scientist Office. Revenue is generated through successful commercialisation of NHS innovations including licensing deals, equity in spinouts, and commercial licence agreements.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels8 records

InnoScot Health product offering

Product offering

Core offering

InnoScot Health is a publicly funded healthcare innovation support agency that works in partnership with NHS Scotland to identify, protect, develop and commercialise innovations originating from healthcare professionals. It delivers an end-to-end innovation pathway covering idea evaluation, intellectual property protection (patents, trademarks, copyright and design rights), regulatory compliance, funding facilitation, and commercialisation support leading to licensing deals or spin-out company formation. Its services are provided at no direct cost to NHS Scotland staff, with revenue generated through successful commercialisation, licensing royalties and equity in spinouts.

Product overview

InnoScot Health is a healthcare innovation support agency operating as a platform-plus-services model. Rather than a single unified product, it offers a comprehensive innovation pathway spanning idea evaluation, IP protection, regulatory compliance, funding, development, and commercialisation. Its portfolio includes supported medical devices (SCRAM Portfolio, Patient Transfer Scale, Cozy Cuddle Scrubs), digital health tools (Decision Support Tools, iGrading, Peekaboo Vision), and spinout companies (Aurum Biosciences, CardioPrecision, MR CoilTech). The organisation has received and evaluated over 2000 innovative ideas, protected over 250 NHS inventions, and formed 7 spin-out companies.

Differentiator

Problem solved

Functional benefit

Products and services

  • SCRAM Portfolio (Structured CRitical Airway Management) Airway management solution for critically unwell patients, including the Paediatric SCRAM Bag adopted at a Glasgow children's hospital and the Surgical SCRAM for theatre settings. Licensed/commercialised via InnoScot Health's NHS innovation pathway for use by hospitals and clinical teams.
  • Patient Transfer Scale Medical device enabling accurate weight measurement of patients during transfer without requiring additional handling steps. Commercialised via InnoScot Health's NHS innovation pathway for use in hospital and clinical settings.
  • Cozy Cuddle Scrubs (by Stacey) Modified theatre scrubs enabling birthing partners to provide immediate skin-to-skin contact with newborns after caesarean section, made from cost-effective upcycled NHS fleeces. Developed for NHS neonatal and maternity care settings.
  • Rhinopinch Simple but effective medical device for nasal treatment, developed and commercialised through the NHS Scotland innovation pathway by InnoScot Health.
  • SARUS Hood Respiratory/airway device for patient care, supported and commercialised through the InnoScot Health NHS Scotland innovation pathway.
  • iGrading Platform Diabetic retinopathy screening tool using automated image grading, developed with NHS Grampian and the University of Aberdeen and commercialised through InnoScot Health for NHS and clinical use.
  • Peekaboo Vision Eye health application for vision screening and assessment, created by NHS Greater Glasgow and Clyde and commercialised through the InnoScot Health innovation pathway.
  • Decision Support Tools (Scotland) National digital decision support platform providing a once-for-Scotland source of digital tools to support clinical decision-making across NHS Scotland, commercialised via InnoScot Health.
  • NHS Innovation Support and Commercialisation Services End-to-end innovation pathway services for NHS Scotland healthcare professionals and partner organisations, covering idea evaluation, intellectual property protection, regulatory compliance, funding access, development management and commercialisation. Provided at no direct cost to NHS Scotland staff under the Scottish Government Chief Scientist Office remit.

Quantifiable outcome

  • Over 2,000 innovative ideas received and evaluated since 2002
  • +3 more outcomes

Companies that use InnoScot Health

Customer profile

Named customers7 records

Segments3 records

Ideal customer profiles3 records

InnoScot Health technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

InnoScot Health partnerships and signals

Strategic signal

Partnerships

14 partnerships are on record, tiered regional, significant, core, major and spinout.

  • NHS GrampianregionalStrategic or Co-development Partner · 1 April 2023Regional partnership for innovation competition stimulating innovative thinking in the north east of Scotland with unique healthcare requirements.
  • MR CoilTechsignificantStrategic or Co-development Partner · 1 April 2022Signed contract in 2022 to provide ISO 13485:2016 Quality Management System implementation and ongoing regulatory advice and project management for MRI RF coil manufacturer.
  • NHS ScotlandcoreStrategic or Co-development PartnerInnoScot Health works in formal partnership with NHS Scotland to identify, protect, develop and commercialise new innovations from healthcare professionals. This is the organisation's primary partnership and reason for existence.
  • Scottish Government Chief Scientist OfficecoreStrategic or Co-development PartnerActivity overseen by the Scottish Government's Chief Scientist Office with annual operating plans aligned to strategic objectives and funding provisions.
  • NHS TaysidecoreStrategic or Co-development PartnerOne of three equal co-owners of InnoScot Health (alongside Scottish Ministers and NHS Golden Jubilee) representing the NHS in Tayside region.
  • NHS Golden JubileecoreStrategic or Co-development PartnerOne of three equal co-owners of InnoScot Health representing the Golden Jubilee National Hospital and regional surgical centre.
  • NHS Clinical Entrepreneur Programme (CEP) PartnerscoreStrategic or Co-development PartnerCollaborative group supporting Scottish participation in NHS CEP including Digital Health & Care Innovation Centre (DHI), NHS Education for Scotland (NES), Techscaler, Scottish Enterprise, and Chief Scientist Office.
  • Tay Health Tech InitiativemajorStrategic or Co-development PartnerEPSRC-funded initiative led by University of Dundee and Heriot-Watt University; InnoScot Health is on the steering committee providing regulatory expertise to support MedTech innovators in Tayside region.
  • Scottish EnterprisemajorStrategic or Co-development PartnerKey funding and business development partner providing access to grants, investment, and commercialisation support for healthcare innovators.
  • Digital Health & Care Innovation Centre (DHI)majorStrategic or Co-development PartnerCollaboration between Glasgow School of Art and University of Strathclyde providing expertise in digital health and social care innovation; co-presenter of ecosystem workshops with InnoScot Health.
  • MHRA (Medicines and Healthcare products Regulatory Agency)majorTechnology or IntegrationUK regulatory body responsible for regulating medicines and medical devices; InnoScot Health provides regulatory expertise aligned with MHRA requirements for UK market access.
  • CardioPrecisionspinoutStrategic or Co-development PartnerInnoScot Health spinout company advancing less invasive cardiovascular surgical solutions; lifesaving technology for structural heart disease making international impact.
  • Aurum BiosciencesspinoutStrategic or Co-development PartnerNHS spinout developing breakthrough stroke technology with potential new treatments; showcasing innovation at international life sciences events.
  • Touch BionicsspinoutStrategic or Co-development PartnerInnoScot Health's first spinout success; received six-figure investment from Scottish Enterprise for next generation prosthetics development.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

InnoScot Health competitors and assessment

Company assessment

Broad incumbents

  • NIHR (National Institute for Health and Care Research): UK government agency that funds, enables, and delivers health and care research across the NHS. Overlaps with InnoScot's translational and commercialisation remit as a much larger national infrastructure body.
  • Wellcome Trust: Major charitable foundation funding health research and translation, including translational funding programmes that overlap with InnoScot's commercialisation pathway. Operates at much larger scale across UK and globally.
  • Cancer Research UK Commercial Partnerships: Translational arm of Cancer Research UK that develops and commercialises discoveries from CRUK-funded research via spinouts, licences, and industry collaborations. Highly analogous innovation-to-commercialisation model in a different therapy vertical.
  • Scottish Enterprise (Life Sciences team): Scotland's national economic development agency with a dedicated Life Sciences team providing commercialisation funding and support to health businesses. Directly listed as an InnoScot partner and operates an overlapping Scottish remit.

Direct peers

  • Health Innovation Manchester: Greater Manchester's NHS-academic-industry innovation partnership identifying, developing, and commercialising innovations. Operates a structurally similar NHS innovation intermediary model in a different UK region.
  • LifeArc: UK medical research charity that translates early-stage science into treatments, diagnostics, and medical devices. Comparable mission of moving NHS-adjacent research into commercial outcomes via spinouts and licensing.
  • NHS Clinical Entrepreneur Programme: NHS-wide programme supporting clinical entrepreneurs with mentoring, education, and commercialisation support. Shares InnoScot's NHS-innovator support mission and is an active partner in Scotland.
  • Health Innovation Network (AHSN Network): The 15 Health Innovation Networks (formerly Academic Health Science Networks) across England provide NHS-aligned innovation support, adoption, and commercialisation services. Closest direct functional peers to InnoScot Health operating within the NHS ecosystem.

Regional players

  • MedCity: London-focused life sciences and MedTech cluster organisation promoting investment, commercialisation, and industry partnerships. Comparable NHS-academia-industry bridge role but operating in a different UK geography.

Emerging players

  • Digital Health & Care Innovation Centre (DHI): Scottish innovation centre focused on digital health and social care co-design between academia, NHS, and industry. Active InnoScot partner with partially overlapping scope in digital health innovation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

InnoScot Health social profiles

Digital presence

InnoScot Health compliance and trust

Trust signal

Compliance3 records

InnoScot Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

InnoScot Health leadership team

Management profile

Number of profiles

InnoScot Health funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

InnoScot Health M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about InnoScot Health

What does InnoScot Health do?

InnoScot Health is a publicly funded healthcare innovation support agency that works in partnership with NHS Scotland to identify, protect, develop and commercialise innovations originating from healthcare professionals. It delivers an end-to-end innovation pathway covering idea evaluation, intellectual property protection (patents, trademarks, copyright and design rights), regulatory compliance, funding facilitation, and commercialisation support leading to licensing deals or spin-out company formation. Its services are provided at no direct cost to NHS Scotland staff, with revenue generated through successful commercialisation, licensing royalties and equity in spinouts.

Is InnoScot Health a public or private company?

InnoScot Health is a private company. It is classified as state government owned and is currently operating.

When was InnoScot Health founded?

InnoScot Health was founded in 2002. It employs 11 to 50 people.

Where is InnoScot Health based?

InnoScot Health is headquartered in Glasgow, United Kingdom, in the Europe region.

How does InnoScot Health make money?

One revenue line is on record: NHS Innovation Support Services.

Who are InnoScot Health's main competitors?

Broad incumbents on record are NIHR (National Institute for Health and Care Research), Wellcome Trust, Cancer Research UK Commercial Partnerships and Scottish Enterprise (Life Sciences team). Direct peers are Health Innovation Manchester, LifeArc, NHS Clinical Entrepreneur Programme and Health Innovation Network (AHSN Network). MedCity is listed as a regional player. Digital Health & Care Innovation Centre (DHI) is listed as an emerging player.

Does InnoScot Health have an API?

No public API is recorded for InnoScot Health.

What industry is InnoScot Health in?

InnoScot Health's product category is Healthcare Innovation Services. Its primary akta.pro industry code is BPAGALAG, Health Access & Social Care Innovations (Community Health, Telehealth for Underserved), with a secondary code of BPADAIAA, Communicable Disease Prevention & Control (HIV/AIDS, TB, Malaria, NTDs).

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PharmafileScots neonatal innovations target hearing loss and earlier careScottish neonatal units are rolling out a 26-minute cheek-swab test to identify babies at risk of hearing loss from gentamicin. The programme, led by CfSD, could save over £199,000 in NHS costs over five years and £14.5m in societal benefits. Other innovations include home jaundice light therapy and modified scrubs for skin-to-skin contact.Scotland NewsThe future of elderly care may already be hereAI-enabled robots are already used in UK homes for medication reminders and companionship, with Cera acquiring GenieConnect to expand adoption. Cera says its robots boost care capacity by 20% and save up to £11,500 per patient annually. Wider rollout is planned over 18 months.PharmiWeb.comNHS Scotland takes ‘world-leading step’ in further reducing healthcare emissions across the countryNHS Scotland's Green Healthcare Scotland initiative, led by the Centre for Sustainable Delivery, is extending its carbon-cutting approach to renal and endoscopy services, which are among the most resource-intensive healthcare areas. Innovation support agency InnoScot Health has endorsed this expansion as a timely and world-leading step toward greener healthcare. NHS Scotland aims to achieve net zero by 2040, having already stopped using high-emission anaesthetic gases desflurane and nitrous oxide in hospital theatres.FutureScotContinued investment into surgical robotics will reduce strain on Scotland’s healthcare system, says innovation agencyInnoScot Health, an innovation agency working to advance healthcare technology in Scotland, has stated that continued investment in surgical robotics will help reduce strain on the NHS and improve patient outcomes, citing the recent £2.5 million funding commitment to NHS Forth Valley for Da Vinci robotic-assisted surgery. The agency noted that approximately £25 million has been invested to date across Scotland, with over 10,000 patients having benefited from robotic-assisted surgery since the Scottish Government began rolling out the technology five years ago. Additional milestones include University Hospital Hairmyres completing its 500th procedure and NHS Ayrshire and Arran delivering robotic gynaecology surgery to over 400 women since 2023.Med-Tech InsightsDiagnostics-on-wheels innovation offers ‘huge potential for national rollout’NHS Greater Glasgow and Clyde has launched a two-year project featuring an enhanced community diagnostic vehicle offering doorstep X-rays, ultrasounds, and blood/urine tests—a UK first for mobile ultrasound capability. Data from a previous pilot showed the service reduced patient waiting times by four hours on average and freed up 9.3 hospital bed days per patient, saving over £1,000 per patient while reducing A&E visits and hospital admissions. Healthcare innovation organization InnoScot Health is promoting the initiative as having 'huge potential for national rollout' and believes it could help address a 13.4% vacancy rate for diagnostic radiographers.PharmiWeb.comScottish A&E departments’ ability to give warm reception to older patients this winter is ‘huge step’All 30 of Scotland's emergency departments (A&E) have now been boosted by having frailty services on hand to support older patients as soon as they arrive, providing rapid comprehensive geriatric assessments. The expansion aims to reduce hospital stays, accelerate early discharge, and free up beds by allowing patients to return under supervision to their own homes. InnoScot Health is seeking ideas from health and social care professionals to drive further innovation in frailty care as Scotland addresses an aging population where 35% of those over 65 are mildly frail, 15% moderately frail, and 5% severely frail.DIGITScots Biopharma Firm Gets New Funding for Innovative TechScottish biopharmaceutical firm Aurum Biosciences has raised nearly £730,000 in the first tranche of a new funding round to develop its ABL-101 therapeutic and diagnostic technology. The investment is supported by existing and new investors including InnoScot Health, Scottish Enterprise, and co-founder Dr Celestine Santosh. This capital will advance the platform ahead of further planned growth and clinical trials for conditions such as stroke and spinal cord injury.PharmiWeb.comInnoScot Health hails ‘fantastic’ funding for MHRA projectsInnoScot Health has announced a new government funding of £1 million to support three projects aimed at advancing regulatory innovation within the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK. The funding will enable improvements in patient access to treatments in clinical trials, the introduction of artificial intelligence in clinical settings, and the establishment of guidelines for microbiome products. This funding aims to accelerate important regulatory innovations that ultimately enhance patient healthcare delivery.PharmiWeb.comCardioPrecision Announces New InvestmentCardioPrecision Ltd secured new equity financing in a bridging round led by existing investors including London & Scottish Investment Partners and Discovery Investment Fund. The funding enables the company to launch its CoreVista® technology for structural heart disease treatment following the relaxation of international COVID restrictions. InnoScot Health also participated in this investment round for the first time since spinning out the company.